Form 8-K - Current report:
SEC Accession No. 0001664710-26-000050
Filing Date
2026-08-03
Accepted
2026-08-03 16:07:39
Documents
36
Period of Report
2026-08-03
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kros-20260803.htm   iXBRL 8-K 34301
2 EX-99.1 a826corporatepresentatio.htm EX-99.1 32246
6 a826corporatepresentatio001.jpg GRAPHIC 90312
7 a826corporatepresentatio002.jpg GRAPHIC 269543
8 a826corporatepresentatio003.jpg GRAPHIC 156722
9 a826corporatepresentatio004.jpg GRAPHIC 63952
10 a826corporatepresentatio005.jpg GRAPHIC 118415
11 a826corporatepresentatio006.jpg GRAPHIC 170574
12 a826corporatepresentatio007.jpg GRAPHIC 83517
13 a826corporatepresentatio008.jpg GRAPHIC 144800
14 a826corporatepresentatio009.jpg GRAPHIC 145983
15 a826corporatepresentatio010.jpg GRAPHIC 165716
16 a826corporatepresentatio011.jpg GRAPHIC 159285
17 a826corporatepresentatio012.jpg GRAPHIC 163072
18 a826corporatepresentatio013.jpg GRAPHIC 151129
19 a826corporatepresentatio014.jpg GRAPHIC 70202
20 a826corporatepresentatio015.jpg GRAPHIC 163184
21 a826corporatepresentatio016.jpg GRAPHIC 173289
22 a826corporatepresentatio017.jpg GRAPHIC 131639
23 a826corporatepresentatio018.jpg GRAPHIC 125218
24 a826corporatepresentatio019.jpg GRAPHIC 156614
25 a826corporatepresentatio020.jpg GRAPHIC 94981
26 a826corporatepresentatio021.jpg GRAPHIC 105826
27 a826corporatepresentatio022.jpg GRAPHIC 144849
28 a826corporatepresentatio023.jpg GRAPHIC 78768
29 a826corporatepresentatio024.jpg GRAPHIC 93852
  Complete submission text file 0001664710-26-000050.txt   4637942

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kros-20260803.xsd EX-101.SCH 1782
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kros-20260803_lab.xml EX-101.LAB 22548
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kros-20260803_pre.xml EX-101.PRE 13046
39 EXTRACTED XBRL INSTANCE DOCUMENT kros-20260803_htm.xml XML 2823
Mailing Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421
Business Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421 617-314-6297
Keros Therapeutics, Inc. (Filer) CIK: 0001664710 (see all company filings)

EIN.: 811173868 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39264 | Film No.: 261232889
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)